ADMA Biologics Inc (ADMA)

Debt-to-assets ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands 72,337 101,326 131,074 130,847 130,594 142,026 140,312 144,301 142,833 141,366 139,811 138,423 94,866 94,363 93,877 93,413 92,969 97,044 96,574 96,129
Total assets US$ in thousands 488,678 390,618 376,399 350,875 329,182 348,997 343,027 340,788 348,461 300,558 296,932 308,032 276,253 238,640 232,814 235,667 207,673 189,976 191,542 210,524
Debt-to-assets ratio 0.15 0.26 0.35 0.37 0.40 0.41 0.41 0.42 0.41 0.47 0.47 0.45 0.34 0.40 0.40 0.40 0.45 0.51 0.50 0.46

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $72,337K ÷ $488,678K
= 0.15

The debt-to-assets ratio of ADMA Biologics Inc has shown fluctuations over the period from March 31, 2020, to December 31, 2024. The ratio started at 0.46 in March 2020, increased gradually to 0.51 by September 2020, then dipped to 0.40 by March 2021. From March 2021 to December 2021, the ratio decreased to 0.34, before rising again to 0.47 by June 2022. The ratio remained relatively stable around 0.40 from September 2022 to March 2024, indicating a moderate level of debt compared to total assets. However, a significant drop was seen by the end of December 2024, with the ratio plummeting to 0.15. This suggests a substantial decrease in debt relative to total assets, possibly indicating improved financial stability or a strategic shift in the capital structure of ADMA Biologics Inc.